Israel Englander’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Israel Englander’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-328,593	Closed	-$1.61M	–	6719
2024 Q1	$1.61M	Buy	+328,593	New	+$1.56M	﹤0.01%	3912
2023 Q3	–	Sell	-20,919	Closed	-$71.1K	–	6706
2023 Q2	$71.1K	Buy	+20,919	New	+$75.4K	﹤0.01%	5401
2023 Q1	–	Sell	-10,655	Closed	-$58K	–	7048
2022 Q4	$58K	Buy	+10,655	New	+$62.7K	﹤0.01%	5737
2022 Q2	–	Sell	-252,509	Closed	-$1.78M	–	7670
2022 Q1	$1.78M	Buy	+252,509	New	+$1.77M	﹤0.01%	3999

Israel Englander's TGAN Position: Q2 2024 in Review

Israel Englander sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 328,593 shares — an estimated $1.61M sold.

Israel Englander first reported a position in TGAN in Q1 2022 and held it in 4 quarters. The position peaked at $1.78M in Q1 2022. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

Israel Englander reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Israel Englander sold 328,593 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $1.61M.
Israel Englander first reported a position in Transphorm, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Israel Englander's Transphorm, Inc. Common Stock position peaked at $1.78M in Q1 2022.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.